Wellgistics Health (WGRX) Common Equity (2023 - 2026)

Wellgistics Health has reported Common Equity for 4 years, with the latest figure at -$15.1 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity fell 436.31% year-over-year to -$15.1 million; the trailing twelve-month figure through Mar 2026 stood at -$15.1 million (down 436.31% YoY), and the FY2025 full-year result was -$12.4 million, down 284.84% from the prior year.
• Common Equity for Q1 2026 stood at -$15.1 million, down from -$12.4 million in the prior quarter.
• The five-year high for Common Equity was $10.0 million in Q3 2024, with the low at -$15.1 million in Q1 2026.
• Historically, Common Equity has averaged -$766054.5 across 4 years, with a median of -$997589.5 in 2023.
• Annual changes were most pronounced in 2024 — Common Equity jumped 332.19% — and 2026, when it tumbled 436.31%.
• Wellgistics Health's Common Equity stood at -$2.9 million in 2023, then jumped by 332.19% to $6.7 million in 2024, then slumped by 284.84% to -$12.4 million in 2025, then retreated by 21.0% to -$15.1 million in 2026.
• The last three Common Equity figures came in at -$15.1 million (Q1 2026), -$12.4 million (Q4 2025), and $6.8 million (Q3 2025), per Business Quant data.